sulindac
Selected indexed studies
- Sulindac and polyp regression. (Cancer Metastasis Rev, 1994) [PMID:7712590]
- Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium. (Drug Metab Rev, 1981) [PMID:7040018]
- Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cells. (J Cancer Res Clin Oncol, 2024) [PMID:39198302]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Sulindac and polyp regression. (1994) pubmed
- Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium. (1981) pubmed
- Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cells. (2024) pubmed
- Sulindac and its derivatives: a novel class of anticancer agents. (2001) pubmed
- Sulindac (Clinoril) hepatitis. (1981) pubmed
- Sulindac therapy of colorectal polyps in familial adenomatous polyposis. (1994) pubmed
- Sulindac hepatotoxicity. (1983) pubmed
- Sulindac-associated choledocholithiasis. (2001) pubmed
- [Sulindac--drug therapy for familial adenomatous polyposis?]. (1993) pubmed
- The developmental toxicity of indomethacin and sulindac. (1995) pubmed